For AI assistants & researchers — machine-readable summary of this page
What this page is: Delvantic's full research page for Ameriprise Financial, Inc. (AMP) — AI-driven forensic equity research: mechanical valuation models (DCF, EPV, anchored-PE, scenario) plus three independent AI lenses (Quality / Value / Sentiment). Everything below is rendered server-side; you are not missing content that requires JavaScript. All scores are predictions and research opinions, not financial advice.
Our current read (analysis of 2026-08-23): Designation Watch · Gem Score +32 (−100…+100 Quality+Value blend) · Quality 58 · Value 10 · Sentiment 49 (timing only, not weighted) · Composite fair value $987.19 vs $569.54 at analysis
Page map (sections in order; each card carries a stable
reference-name attribute you can cite):
profile-header/price-overview— company profile, live quote, market capextended-analysis— the core: three AI lens reads with findings, scores, and the analyst memofuture-predictions— our forward price-band predictionsmarket-narrative/ai-findings/gpt-critique— narrative context, cross-model findings, and an adversarial critique of our own analysis (near the end of the document)- Members-only sections (render as login gates for anonymous readers):
price-history,income-trend,key-metrics,financials(statement tables),insider-trading. The analysis above is public; the raw data tables require a free account.
More for machine readers: site briefing at
/llms.txt ·
any ticker resolves at delvantic.com/stock/TICKER ·
raw inputs are public-company filings and market data (via licensed data feeds);
every model, score, lens read, and prediction on this page is Delvantic's own analysis.
Ameriprise Financial, Inc.
AMP NYSEAmeriprise Financial, Inc. is a diversified financial services company that provides wealth management, asset management, and insurance solutions to individual and institutional clients. The firm focuses on comprehensive financial planning, offering advisory services through a large network of financial advisors who help clients with retirement planning, investment strategies, and protection needs. Its operations are organized into key segments including Advice & Wealth Management, Asset Management, and Retirement & Protection Solutions, along with a Corporate & Other segment that supports its core activities. Through its wealth management and advisory arm, Ameriprise Financial delivers personalized portfolios, brokerage services, and financial guidance. Its asset management capabilities cover a range of investment products and strategies designed for different risk profiles and objectives. The company also provides retirement products and insurance solutions that address income, longevity, and risk management needs. Headquartered in Minneapolis, Minnesota, Ameriprise Financial plays a notable role in the U.S. financial ecosystem as an integrated provider of planning, investment, and protection services across multiple client segments.
Price Overview
Price History (1 Year)
Revenue & Net Income Trend
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
EPS (Diluted): 36.28
Total Equity: $6.55B
Shares: 98,208,379
Total Debt: $0.00
Cash: $11.16B
EBITDA: N/A
Total Debt: $0.00
Cash: $11.16B
Revenue: $18.48B
Revenue: $18.48B
Revenue: $18.48B
Total Equity: $6.55B
Tax Rate: 20.9%
Equity: $6.55B
Total Debt: $0.00
Cash: $11.16B
Current Liabilities: N/A
Long-Term Debt: $0.00
Total Debt: $0.00
Total Equity: $6.55B
Shares: 98,208,379
Shares: 98,208,379
CapEx: -$162.00M
Shares: 98,208,379
Stock Price: $569.54
Net Income: $3.56B
Industry Benchmarks
Income Statement (Annual)
Last updated: Aug 12, 2026 10:14am (11d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $13.4B | $14.3B | $15.5B | $17.3B | $18.5B |
| Cost of Revenue | — | — | — | — | — |
| Gross Profit | — | — | — | — | — |
| Operating Expenses | $8.5B | $8.7B | $8.9B | $9.9B | $10.6B |
| Operating Income | — | — | — | — | — |
| Net Income | $3.4B | $3.1B | $2.6B | $3.4B | $3.6B |
| EBITDA | — | — | — | — | — |
| EPS | $29.13 | $28.29 | $24.18 | $33.67 | $36.85 |
| EPS (Diluted) | $28.48 | $27.70 | $23.71 | $33.05 | $36.28 |
Balance Sheet (Annual)
Last updated: Aug 17, 2026 12:20am (6d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $9.6B | $8.8B | $8.6B | $9.5B | $11.2B |
| Total Current Assets | — | — | — | — | — |
| Total Assets | $176.0B | $158.5B | $175.2B | $181.4B | $190.9B |
| Current Liabilities | — | — | — | — | — |
| Long-Term Debt | — | — | — | — | — |
| Total Liabilities | $170.3B | $154.9B | $170.5B | $176.2B | $184.4B |
| Total Equity | $5.7B | $3.6B | $4.7B | $5.2B | $6.5B |
| Retained Earnings | $17.5B | $19.5B | $21.9B | $24.7B | $27.7B |
Cash Flow (Annual)
Last updated: Aug 17, 2026 12:39am (6d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $3.3B | $4.4B | $4.7B | $6.6B | $8.3B |
| Capital Expenditure | -$120.0M | -$182.0M | -$184.0M | -$176.0M | -$162.0M |
| Free Cash Flow | $3.2B | $4.2B | $4.5B | $6.4B | $8.2B |
| Acquisitions (net) | -$576.0M | $34.0M | $0 | $0 | — |
| Net Debt Issued / (Repaid) | -$9.0M | -$510.0M | -$760.0M | -$561.0M | -$510.0M |
| Dividends Paid | -$511.0M | -$534.0M | -$550.0M | -$574.0M | -$596.0M |
| Stock Buybacks | -$2.0B | -$2.0B | -$2.1B | -$2.4B | -$2.9B |
| Net Change in Cash | $666.0M | -$814.0M | -$135.0M | $869.0M | $1.7B |
Growth Trends (YoY %)
Last updated: Aug 12, 2026 10:14am (11d ago)| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | +6.6% | +9.0% | +11.1% | +7.0% |
| Gross Profit Growth | — | — | — | — |
| Operating Income Growth | — | — | — | — |
| Net Income Growth | -7.8% | -18.8% | +33.1% | +4.8% |
| EBITDA Growth | — | — | — | — |
Dividend History (Last 20)
Last updated: Aug 12, 2026 10:14am (11d ago)| Date | Dividend | Declaration | Record | Payment |
|---|---|---|---|---|
| 2026-08-03 | $1.70 | — | — | — |
| 2026-05-04 | $1.70 | — | — | — |
| 2026-02-09 | $1.60 | — | — | — |
| 2025-11-10 | $1.60 | — | — | — |
| 2025-08-04 | $1.60 | — | — | — |
| 2025-05-05 | $1.60 | — | — | — |
| 2025-02-10 | $1.48 | — | — | — |
| 2024-11-04 | $1.48 | — | — | — |
| 2024-08-05 | $1.48 | — | — | — |
| 2024-05-03 | $1.48 | — | — | — |
| 2024-02-08 | $1.35 | — | — | — |
| 2023-11-03 | $1.35 | — | — | — |
| 2023-08-04 | $1.35 | — | — | — |
| 2023-05-05 | $1.35 | — | — | — |
| 2023-02-09 | $1.25 | — | — | — |
| 2022-11-04 | $1.25 | — | — | — |
| 2022-08-05 | $1.25 | — | — | — |
| 2022-05-06 | $1.25 | — | — | — |
| 2022-02-10 | $1.13 | — | — | — |
| 2021-11-05 | $1.13 | — | — | — |
Deep Analysis
Risk : Reward — if the last quarter repeats
Live · as of 2026-08-19 08:29Recovery pays +13%; another quarter like the worst recent one costs 28%. Ratio 0.5:1. Caveat: revenue-DCF fits financials poorly (reported revenue omits net interest) — treat the legs as rough.
| Case | Growth | Margin | Fair value | vs price ($569.54) |
|---|---|---|---|---|
| Bull — recovery | +18% | 23.6% | $644.96 | +13% |
| Base — stabilizes | +12% | 20.5% | $477.12 | -16% |
| Bear — keeps slipping | +6% | 17.4% | $345.87 | -39% |
| Stress — last quarter repeats | +7% | 20.3% | $412.86 | -28% |
Narrative Economics
market-narrative step).
AI Lens 4th lens · how AI reaches this business · 5-yr
2026-08-17Ameriprise charges basis points on ~advisory and wrap assets and earns spread on bank/certificate cash; neither unit shrinks when intelligence gets cheap, while the cost stack it takes to deliver — call centers, account servicing, compliance supervision of a ~10k-advisor network, investment research — is exactly what AI deflates.
Cheap AI commoditizes the analytical content of both active asset management (Columbia Threadneedle) and financial planning itself, pressuring fee rates at both ends: institutional/retail active fee decay plus eventual downward drift in the ~1% advisory fee as clients see the planning deliverable produced instantly.
Whether AI raises Ameriprise's assets-per-advisor and cuts unit servicing cost faster than realized fee rates decline — observable in AWM pretax margin and the reported advisory fee yield on wrap assets, not in headline AUM.
Broker-dealer and insurance licensing, fiduciary/suitability accountability, custody of client money, decades of household relationships with retiring mass-affluent savers, and a franchise advisor network that is far harder to assemble than the software that serves it.
AI Lens thesis
The need — someone accountable for a household's retirement money — is untouched by AI, and the monetized unit is asset-linked, so cheaper intelligence does not mechanically shrink revenue the way it shrinks seats or billable hours; it lands first on cost, where Ameriprise carries a heavy servicing, supervision and research base, and on advisor capacity, where AI lets each advisor hold more households at the same payout grid. The offsets are real and specific: Columbia Threadneedle's active franchise is the leg where AI most directly commoditizes the product, already losing share; and AI-assembled turnkey RIA infrastructure lowers the cost of independence, weakening the platform value Ameriprise extracts from franchise advisors. Net: cost deflation on an asset-linked revenue base is a favorable trade, with the asset-management segment and advisor retention as the drags.
What the market may be underestimating
Upside Compliance and supervision — the cost of policing thousands of advisors' communications and suitability — is one of the highest-value AI automation targets in the firm and is invisible in segment disclosure until margin moves; the same tooling makes Ameriprise a cheaper home for recruited advisors.
Downside AI-native planning and portfolio tooling collapses the fixed cost of running a standalone RIA; the franchise advisor who once needed Ameriprise's platform, compliance and brand needs less of it, compressing the platform's share of the client fee even as client assets stay put.
Outcome range spread 45 · unresolved
Growth Outlook
Analyzed 2026-08-17 16:35The question every valuation on this page silently assumes: is this company likely to grow? Judged forward — the business, its category, the world — against what's already printed.
Claude Reading
Looking at the raw numbers first: AMP is running $19.9B TTM revenue (sum of last four quarters: 5.01+4.89+5.05+4.89) versus $17.26B in 2024 — that's 15% growth, faster than the 9.1% CAGR headline suggests. TTM net income is roughly $3.95B, giving a trailing P/E closer to 12.7x, not the 15.7x annual figure. On $8.16B FCF against a $50B market cap, that's a 16% FCF yield. Those are cheap-looking numbers for a business posting 54% ROE. But the quarterly margin volatility is real and worth interrogating — Q1'25 dropped to 13% net margin, Q3'24 to 11.2%, while other quarters print 20-23%. That's not noise in a fee business; that's mark-to-market on the insurance/annuity book or DAC amortization swings, which the market rightly discounts.
The Valuation Synthesis output — fair value $987, signal-adjusted $1,267, implying +122% upside — is almost certainly garbage and I'd throw it out. A DCF that spits out 2.2x current price on a mature financial with 9% revenue growth and lumpy earnings is either (a) using a discount rate inappropriate for an insurance-exposed balance sheet, (b) capitalizing peak-cycle FCF, or (c) ignoring that AMP's "equity" of $6.55B is a fraction of its economic capital footprint — the 54% ROE is partly a leverage artifact of the insurance liabilities that aren't showing in the debt line ("Total debt: —" is a data gap, not zero). Trusting a $1,267 target here is exactly the kind of model error that gets analysts fired. The Market Forces "neutral" and Narrative layer's "fundamentals doing the work, no story premium" reads are much more defensible: the discount is rational, not a mispricing.
The contrarian case against even a modest long: AMP's earnings are heavily levered to equity market AUM and net interest income on cash sweep balances. We're in year 6+ of a bull market; if AUM contracts 20% in a drawdown, fee revenue drops proportionally while fixed advisor comp and tech spend don't. The Q1'25 and Q3'24 margin compressions hint at how quickly this line item moves. Insider activity shows exercise-and-sell patterns on 7/28/2026 — routine but not confidence-inspiring; no open-market buys. The insurance/annuity segment carries duration and lapse risk that isn't visible in these summary tables. Also worth flagging: the data is dated to mid-2026 with a $569 price, and the balance sheet omits total debt entirely — a serious gap for a financial where leverage IS the business.
My read: AMP is cheap on trailing FCF and earnings, and modestly undervalued relative to peers like SCHW, TROW, and BEN on a P/E basis given its growth profile — but nowhere near the synthesis's $987-$1,267 fantasy. Fair value on 13-14x normalized earnings of ~$3.6B (haircut for cycle) is roughly $650-720, or ~15-25% upside plus the 1.2% dividend. That's an "own it, don't chase it" setup, not a table-pounder. I partially agree with the synthesis direction (undervalued) but strongly dissent on magnitude — the composite model is systematically overweighting FCF extrapolation in a business where FCF is cyclically inflated by asset prices and rates. The Market Narrative layer nailed it: this is a transparent, boring business trading at a rational discount to what a naive DCF says. Boring discounts don't close 122%; they close 15-20% when a catalyst (rate cut cycle, AUM inflection, buyback acceleration) arrives.
GPT Reading
What jumps out is not a broken financial, but a very efficient one that the valuation model likely overstates because it treats recent cash flow as more distributable and durable than a financial-services balance sheet really allows. Ameriprise has grown annual revenue from $13.38B in 2021 to $18.48B in 2025, about 38% cumulatively, while net income moved from $3.42B to $3.56B after dipping in 2022 and recovering strongly from $2.56B in 2023. That is a good business, but not a straight-line compounder. The quarterly picture is steadier recently: revenue has risen from $4.48B in 2025-03 to $5.01B in 2026-06, and net income from a depressed $583M to $1.11B, with margin recovering into the 19-22% range. On trailing earnings power, a $50.3B market cap against roughly $4.0B of annualized net income implies a mid-teens multiple for a high-return franchise with modest top-line growth. That feels reasonable to slightly cheap, not remotely the 2x upside the synthesis model suggests.
The quality of the franchise is better than the stock’s “plain financial” label suggests. Ameriprise is generating $8.32B of operating cash flow and $8.16B of free cash flow on $18.48B of revenue, with just $162M of capex, which tells you this is an asset-light advice and asset-management platform rather than a capital-hungry operator. The 54.4% ROE looks spectacular, though it is flattered by a small $6.55B equity base; at 8.5x book, the market is clearly not valuing this on book, but on earnings and cash generation. I think that is correct. For a company producing a 19.3% net margin, 9.1% revenue CAGR, 18.1% earnings CAGR off the recent base, and carrying $11.16B of cash with no reported debt here, 15.7x earnings is not demanding. But it also is not some obvious mispricing when the business remains tied to markets, client asset values, and advisor productivity. This is a good compounding financial, not a hidden hyper-grower.
The main contradiction I see is between the eye-popping free cash flow and ROE metrics and the more ordinary earnings trajectory. Net income was $3.42B in 2021, then $3.15B in 2022, $2.56B in 2023, back to $3.40B in 2024, and $3.56B in 2025. That is resilient, but cyclical and market-sensitive. Quarterly margins also swing hard—11.2% in 2024-09, 23.0% in 2024-12, 13.0% in 2025-03, then back above 20% in later periods. A model that capitalizes the latest cash flow too aggressively can end up producing fantasy fair values for firms where working capital, policyholder flows, and investment-related items muddy “FCF.” So my read is that Ameriprise deserves a premium to many financials because it has a sticky advisory model and strong profitability, but the current price around $570 already reflects a lot of that quality. Fair value looks closer to the mid-$500s to mid-$600s than anywhere near $1,000.
The best case against my restraint is straightforward: the stock could simply be too cheap for a business with this consistency. Revenue is up 7% year over year in the latest quarter, earnings are up 4.8%, quarterly revenue has held near $4.9B-$5.0B for four straight periods, and the latest quarter delivered $1.11B of net income, the best in the set. If that run rate is sustainable, annual earnings power is already north of $4.0B, which puts the stock closer to 12-14x forward earnings. Combine that with a 1.16% dividend yield, only a 16.7% payout ratio, and plenty of capacity for buybacks, and you can argue this should trade more like a premium wealth manager at 17-18x earnings, which would support something like $650-$720. I weigh that lower because the same data also show profits can drop sharply from quarter to quarter, and because asset managers rarely hold peak-ish multiples for long when markets and fee pressure can turn.
What would change my mind is evidence that the recent earnings level is structurally higher rather than just market-assisted. If Ameriprise can put up another two or three quarters around $5.0B of revenue with net income consistently above $1.0B and margins holding above 20%, then the current price would start to look cheap and I’d move toward a $650+ view. On the other side, if revenue stalls back below $4.7B or margins slip toward the low teens again, it would confirm that the stock is already discounting near-best-case conditions and deserves a lower multiple, likely pushing fair value back toward $500 or below.
Grok Reading
The numbers that matter most are not the model’s $1,267 fair-value fantasy but the cash conversion sitting in plain sight. Ameriprise generated $8.16B of free cash flow against an $18.48B revenue base and a $50.3B equity market cap, an FCF yield north of 16% with capex of only $162M. Annual revenue has compounded from $13.38B in 2021 to $18.48B in 2025 (roughly 9% CAGR), net income recovered from the 2023 soft patch of $2.56B to $3.56B, and trailing net margin sits near 19%. Quarterly run-rate revenue is stable in the $4.9–5.0B band with margins oscillating between the high teens and low twenties—lumpiness that is normal for a wealth-and-protection franchise marked to markets, not evidence of collapse. At 15.7x earnings and 3.0x sales, the stock is priced like a no-growth utility while throwing off cash like a capital-light compounder that still grows mid-to-high single digits. The 54% ROE is real in the sense that management keeps the equity base thin ($6.55B) via buybacks and a modest 16.7% payout; that is capital allocation, not alchemy.
Where the quantitative stack overreaches is the 122% upside call. A 15.7x multiple on a mature earner with decelerating recent earnings growth (only +4.8% YoY) and “decelerating” quarterly revenue confidence does not automatically re-rate to 25–30x just because a DCF spits out $987–$1,267. ROA of 1.9% is the tell: this is a large-balance-sheet financial whose headline ROE is leverage and treasury management as much as economic moat. Debt fields reading zero are simply incomplete for an insurer-advisor hybrid; policyholder liabilities and spread books are the real leverage. Fee-based AUM is cyclical, advisor economics face ongoing pressure, and the insurance sleeve carries duration and claims inflation risk the market has refused to ignore for years. Insider tapes are noise—option exercise followed by sales on a single July day is compensation mechanics, not a signal.
The strongest opposing case is that the discount is earned. Market Forces correctly flag competitive erosion and digital substitution; the narrative layer is “anchored” precisely because skeptics have a coherent story—robo advice, direct indexing, and fee compression steadily bleed pricing power while organic growth slows toward mid-single digits. If normalized FCF is closer to $5–6B after insurance adjustments and working-capital noise, the true yield compresses toward 10–12% and a mid-teens earnings multiple looks fair, not cheap. The 8.5x price-to-book multiple on a shrinking book also means any halt in buybacks or a capital build for regulatory reasons would remove the ROE prop and expose a less glamorous franchise. I weigh this seriously, but still secondary: even a haircut FCF yield in the low double digits with a 1.2% dividend, sub-20% payout, and sector-leader scale is not the profile of a fully valued stock at $570.
I would flip to fairly valued or worse on two concrete prints: trailing twelve-month organic AUM flows turning sustainably negative, or operating margin compressing through 15% for two consecutive halves without an offsetting capital-return acceleration. I would become aggressively bullish only if revenue re-accelerates above 10% YoY while FCF stays above $7B, proving the fee franchise is still expanding rather than harvesting.
Big-3 Panel — where each AI stands
Advanced Analysis Forensic deep-dive · separate lenses
Revenue grew from 13.44B in 2021 to 18.91B in 2025, a roughly 41 percent lift over four years with no down year, and net income moved from 2.76B to 3.56B. The standout is cash conversion: free cash flow expanded from 3.21B to 8.16B, now materially exceeding reported net income, which is unusual and points to a capital-light, float/fee-driven model where working capital and non-cash items flatter cash rather than the other way around. Diluted share count fell from 120.0M to 98.2M, an 18 percent reduction, meaning every operating gain is amplified on a per-share basis. Margin fields show zero here (financials-industry presentation quirk), so profitability must be inferred from net income and FCF; on that basis net margin sits near 19 percent and FCF/revenue near 43 percent in 2025, both healthy for the industry. Without balance-sheet, dilution-forensics, or earnings-quality modules this run, some risk stays unquantified - insurance/annuity reserves, hedging, and AOCI swings are material at a company like AMP - but the visible trajectory is one of durable growth, real cash, and shareholder-friendly capital return.
Verify before trusting this (6)
- Statutory capital and RBC ratios at the insurance subsidiaries, plus AOCI and unrealized losses on the investment portfolio.
- Composition of FCF: how much is driven by policyholder liabilities and separate-account flows versus true fee-based operating cash.
- Advice and Wealth Management segment net flows and organic growth versus market appreciation contribution.
- Stock-based compensation as a percent of buybacks to confirm the 18 percent share reduction is net of SBC and not gross.
- Debt maturity ladder, holding-company liquidity, and any variable annuity hedging effectiveness disclosures.
- Customer/advisor concentration and retention trends in the AWM franchise.
The e2e composite fair value of $987 and signal-adjusted $1,267 imply 73-122% upside, which strains credulity for a $50B diversified financial services firm the market watches closely. Both inputs (DCF $1,091, anchored-PE $779) sit well above price; I trust the anchored-PE far more than the DCF here. A more defensible deserved value sits closer to $650-720, roughly 14-18x on a mid-teens ROE, cash-generative wealth/asset manager with steady buybacks and growing FCF - a quality profile that deserves a market-ish multiple, not a premium.
Verify before trusting this (5)
- Advisor productivity and net flows trend in Wealth Management
- Spread income sensitivity and hedging in the Retirement & Protection book
- Buyback pace and average repurchase price vs current level
- Fee rate compression in Asset Management segment
- Any one-time items inflating recent FCF
The macro backdrop is friendly: VIX at 14.3, S&P near highs, and a risk-on regime that lets a 1.14-beta financial like AMP participate without being whipped. Higher rates are a mild sector crosswind for asset managers via market-value drag on AUM, but with the curve normalizing and equities firm, that pressure is muted right now. Nothing in the tape is actively pushing this name down. The narrative is the key: intensity is minimal and cult coefficient is low, meaning AMP has no story premium to lose and no story collapse to fear. It trades on numbers, not vibes. Into that vacuum, the last 72 hours delivered unambiguously positive flow: two Zacks Strong Buy adds (both a growth and a value screen), and coverage of a completed 3.44B buyback that retired nearly 8% of shares. That is the kind of quiet, mechanical tailwind that steady-compounders convert into drift-higher price action. Analyst tone is constructive, momentum is already strong_positive, and there is no visible short-narrative (robo/fee-compression) actively de-rating the stock today. Net: a modest tailwind, not a euphoric one - the story is not the driver, but every current input leans the same direction.
Verify before trusting this (4)
- Whether the buyback headline generates follow-through analyst target revisions or is a one-day story
- Any VIX spike or curve re-inversion that would flip the risk-on regime and hit 1.14-beta financials first
- Emergence of a fresh fee-compression or advisor-attrition data point that could activate the dormant bear narrative
- Fund flow data for wealth managers vs pure asset managers to confirm sector tone
The need — someone accountable for a household's retirement money — is untouched by AI, and the monetized unit is asset-linked, so cheaper intelligence does not mechanically shrink revenue the way it shrinks seats or billable hours; it lands first on cost, where Ameriprise carries a heavy servicing, supervision and research base, and on advisor capacity, where AI lets each advisor hold more households at the same payout grid. The offsets are real and specific: Columbia Threadneedle's active franchise is the leg where AI most directly commoditizes the product, already losing share; and AI-assembled turnkey RIA infrastructure lowers the cost of independence, weakening the platform value Ameriprise extracts from franchise advisors. Net: cost deflation on an asset-linked revenue base is a favorable trade, with the asset-management segment and advisor retention as the drags.
None surfaced.
Verify before trusting this (8)
- Advisory fee yield in bps
- Spread revenue on cash/certificates
- Fee rate on managed assets by segment
- Columbia Threadneedle net flows
- Direct-indexing/model portfolio adoption in wrap
- Share of assets in advisory vs brokerage
- AWM pretax operating margin
- G&A per client household
The world is still adding financial-advice demand faster than it is destroying it: wealth transfer, retirement complexity and the shift from transactional brokerage to fee-based planning all favor scaled advisor networks, and an elevated rate curve pays those platforms extra on client cash. Against that, distribution economics are flattening — technology-assisted and low-cost platforms compress the fee a human advisor can defend, and product fees keep sliding toward passive/model-based delivery. Ameriprise sits on the right side of the demand shift and the wrong side of the pricing shift, so its growth is real but structurally capped near the low end of its category. Macro is the wildcard in both directions: rate cuts would trim spread income while lifting asset values, an equity drawdown would reset the fee base directly.
When we made this prediction on Aug 17, 2026, AMP was $569.54. We expect it to be $680.00 by Feb 2027, and we consider it great value under $560.00. This is an early model (v0.6.0) — the direction is more reliable than the exact price. Made Aug 17, 2026.
Blue is our prediction, starting the day we made it. Grey is a slower route to the same place — the same destination, taking longer. Black is the actual price, so you can see how we are doing.